Showing results 99 to 118 of 174
< previous
next >
| Issue Date | Title | Author(s) |
| 2007 | Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells | Baran, Yusuf ; Ural, Ali Uğur; Gündüz, Ufuk |
| 2010 | The mechanisms responsible for Nilotinib resistance in human chronic myeloid leukemia cells | Camgöz, Aylin |
| Jun-2013 | Mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells and reversal of resistance | Camgöz, Aylin; Gençer, Emel Başak; Ural, Ali Uğur; Baran, Yusuf |
| 2015 | Mesenchymal stem cells administered intraperitoneally have a potent effects on the experimental allergic airway disease | Işık, S.; Adan, Aysun ; Karaman, M.; Kiray, M.; Bağrıyanık, H. A.; Çağlayan-Sözmen, S.; Uzuner, N.; Baran, Yusuf |
| Aug-2011 | Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma | Fırıncı, Fatih; Karaman, Meral; Baran, Yusuf ; Bağrıyanık, Alper; Arıkan Ayyıldız, Zeynep; Kiray, Müge; Kozanoglu, İlknur; Yılmaz, Osman; Uzuner, Nevin; Karaman, Özkan |
| 2015 | The microarray gene profiling analysis of acute promyelocytic leukemia cells in response to fisetin and hesperetin | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2023 | MicroRNAs and long non-coding RNAs as novel targets in anti-cancer drug development | Çetinkaya, Melisa; Baran, Yusuf |
| 2018 | A minimally invasive transfer method of mesenchymal stem cells to the intact periodontal ligament of rat teeth: a preliminary study | Gül Amuk, Nisa; Kurt, Gökmen; Kartal Yandım, Melis; Adan, Aysun ; Baran, Yusuf |
| Apr-2013 | miR-17 in imatinib resistance and response to tyrosine kinase inhibitors in chronic myeloid leukemia cells | Fıratlıgil, Burcu ; Biray Avcı, Çığır; Baran, Yusuf |
| Feb-2016 | A molecular and biophysical comparison of macromolecular changes in imatinib-sensitive and imatinib-resistant K562 cells exposed to ponatinib | Kartal Yandım, Melis; Ceylan, Çağatay ; Elmas, Efe; Baran, Yusuf |
| Jul-2016 | Molecular mechanisms of drug resistance and its reversal in cancer | Kartal Yandım, Melis; Adan Gökbulut, Aysun ; Baran, Yusuf |
| Aug-2014 | Molecular mechanisms of quercitrin-induced apoptosis in non-small cell lung cancer | Çinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| 2014 | Multidrug resistance in chronic myeloid leukemia | Ünlü, Miray ; Kiraz, Yağmur ; Kacı, Fatma Necmiye; Özcan, Mehmet Ali; Baran, Yusuf |
| Feb-2009 | Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients | Abaan, Ogan Demir; Mutlu, Pelin Kaya; Baran, Yusuf ; Atalay, Can; Gündüz, Ufuk |
| 2012 | A natural product, quercetin enhances the cytotoxic and apoptotic effects of dexamethasone on jurkat cells | Baran, Yusuf ; Kartal, Melis; Kozanoğlu, İlknur |
| Feb-2013 | New indication for therapeutic potential of an old well-known drug (propranolol) for multiple myeloma | Kozanoğlu, İlknur; Kartal Yandım, Melis; Çinçin, Zeynep Birsu; Özdoğu, Hakan; Çakmakoğlu, Bedia; Baran, Yusuf |
| Oct-2015 | Nilotinib does not alter the secretory functions of carotid artery endothelial cells in a prothrombotic or antithrombotic fashion | Katgı, Abdullah; Sevindik, Ömer Gökmen; Adan Gökbulut, Aysun ; Özsan, Güner Hayri; Yüksel, Faize; Solmaz, Şerife Medeni; Alacacıoğlu, İnci; Özcan, Mehmet Ali; Demirkan, Fatih; Baran, Yusuf ; Pişkin, Özden |
| Feb-2010 | Nilotinib significantly induces apoptosis in imatinib resistant K562 cells with wild-type BCR-ABL, as effectively as in parental sensitive counterparts | Ekiz, Hüseyin Atakan ; Can, Geylani; Gündüz, Ufuk; Baran, Yusuf |
| 2009 | Nilotinib significantly induces apoptosis in imatinib resistant K562 cells, as effectively as in parental sensitive counterparts | Baran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan |
| 2012 | A novel agent, KL-21, has significant anticancer potential on chronic lymphocytic leukemia cells but not on healthy cells | Baran, Yusuf ; Gökbulut, Aysun ; Yaşar, M. |
